Results 11 to 20 of about 883,208 (316)

Systematic testing of literature reported genetic variation associated with coronary restenosis: results of the GENDER Study. [PDF]

PLoS ONE, 2012
BACKGROUND: Coronary restenosis after percutaneous coronary intervention still remains a significant problem, despite all medical advances. Unraveling the mechanisms leading to restenosis development remains challenging.
Jeffrey J W Verschuren, Stella Trompet, Iris Postmus, M Lourdes Sampietro, Bastiaan T Heijmans, Jeanine J Houwing-Duistermaat, P Eline Slagboom, J Wouter Jukema   +7 more
doaj   +2 more sources

Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist)

Cells, 2022
Coronary stents are among the most common therapies worldwide. Despite significant improvements in the biocompatibility of these devices throughout the last decades, they are prone, in as many as 10–20% of cases, to short- or long-term failure.
Tommaso Gori
doaj   +2 more sources

Pathway analysis using genome-wide association study data for coronary restenosis--a potential role for the PARVB gene.

PLoS ONE, 2013
BackgroundCoronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified.
Jeffrey J W Verschuren, Stella Trompet, M Lourdes Sampietro, Bastiaan T Heijmans, Werner Koch, Adnan Kastrati, Jeanine J Houwing-Duistermaat, P Eline Slagboom, Paul H A Quax, J Wouter Jukema   +9 more
doaj   +2 more sources

Drug- and Gene-eluting Stents for Preventing Coronary Restenosis. [PDF]

Chonnam Med J, 2017
Coronary artery disease (CAD) has been reported to be a major cause of death worldwide. Current treatment methods include atherectomy, coronary angioplasty (as a percutaneous coronary intervention), and coronary artery bypass.
Lekshmi KM, Che HL, Cho CS, Park IK.
europepmc   +2 more sources

Changes of Serum CTRP12 in Patients With Coronary Artery Disease After the Treatment of Percutaneous Coronary Intervention and Its Relationship With In-Stent Restenosis. [PDF]

Clin Cardiol
Serum CTRP12 levels are significantly lower in CAD patients, and significant correlate to disease severity and dynamic changes after PCI. They may serve as a potential biomarker for diagnosing CAD and predicting ISR occurrence. ABSTRACT Background C1q/tumor necrosis factor‐related protein 12 (CTRP12) plays a protective role in coronary artery disease ...
Zhao B, Shen Y.
europepmc   +2 more sources

Anti-Inflammatory Effect of Gallic Acid-Eluting Stent in a Porcine Coronary Restenosis Model. [PDF]

Acta Cardiol Sin, 2018
Seob Lim K, Park JK, Ho Jeong M, Ho Bae I, Sung Park D, Won Shim J, Ha Kim J, Kuk Kim H, Soo Kim S, Sun Sim D, Joon Hong Y, Han Kim J, Ahn Y.   +12 more
europepmc   +2 more sources

Inhibition of in-stent stenosis by oral administration of bindarit in porcine coronary arteries [PDF]

, 2011
<p><b>Objective:</b> We have previously demonstrated that bindarit, a selective inhibitor of monocyte chemotactic proteins (MCPs), is effective in reducing neointimal formation in rodent models of vascular injury by reducing smooth ...
Baker, A.H., Biondi, G., Colombo, A., Di Lauro, M.V., Gordon, P., Grassia, G., Guglielmotti, A., Ialenti, A., Kennedy, S., Maddaluno, M., Maffia, P.   +10 more
core   +1 more source

Genous™ endothelial progenitor cell capturing stent vs. the Taxus Liberté stent in patients with de novo coronary lesions with a high-risk of coronary restenosis: a randomized, single-centre, pilot study [PDF]

European Heart Journal, 2009
Aims The purpose of this study was to evaluate the GenousTM endothelial progenitor cell capturing stent vs. the Taxus Liberté paclitaxel-eluting stent in patients with de novo coronary lesions with a high-risk of coronary restenosis.
Marcel A.M. Beijk, Margo Klomp, Niels Verouden, Nan van Geloven, Karel T. Koch, José P.S. Henriques, Jan Baan, Marije M. Vis, Esther M. Scheunhage, Jan J. Piek, Jan G.P. Tijssen, Robbert J. de Winter   +11 more
openalex   +2 more sources

Restenosis After Coronary Angioplasty

Journal of Interventional Cardiology, 1993
Coronary angioplasty is used to treat coronary atherosclerotic disease in many patients. One problem with coronary angioplasty is the phenomenon of restenosis. Restenosis appears to be a universal response to arterial wall injury. The biological events that underlie restenosis are characterized by: platelet adhesion and aggregation at sites of damaged
H V, Anderson, S J, Vignale, C R, Benedict, J T, Willerson   +3 more
openaire   +4 more sources

Use of Nuclear Magnetic Resonance Imaging Angiography to Follow-Up Arterial Remodeling in an Animal Model [PDF]

, 1998
Appropriately sized arteries in small animals may be possible models for studying the remodeling process as occurs after arterial balloon injury in humans. Magnetic resonance imaging (MRI) is able to noninvasively image tissue in vivo.
Berthold Höfling, Johannes Schirmer, Losordo DW, Markus Schwaiger, Mintz GS, Serap Esin, Sigrid Nikol, Stephan Nekolla, Tanya Y. Huehns, Toussaint JF   +9 more
core   +1 more source